PUBLISHER: Arizton Advisory & Intelligence | PRODUCT CODE: 1324771
PUBLISHER: Arizton Advisory & Intelligence | PRODUCT CODE: 1324771
Europe E-Pharmacy Market - Industry Outlook & Forecast 2023-2028
The Europe e-pharmacy market is expected to grow at a CAGR of 17.65% from 2022 to 2028.
MARKET TRENDS & OPPORTUNITIES
Rapidly Growing E-Health & E-prescription
Due to the progressive nature of healthcare and medicine deliveries in Europe, the approach changing from hospital care to homecare deliveries offers huge opportunities in European patient management across all healthcare systems. Growing adoption of e-health solutions such as m-health, telemedicine, and e-prescription help consumers connect directly to health professionals and receive care and consultations at home. Increasing use of e-health applications and increasing allowance to e-prescription drive the high medicine purchasing orders through e-pharmacies that have recently accelerated the Europe e-pharmacy market growth.
Integration of AI, & IoT
Technologies such as artificial intelligence (AI), Machine Learning, and the Internet of Things can make pharmacy technologies more powerful. Europe is a technology-driven market for healthcare systems and pharmaceutical industries. Pharmacies with AI, Machine Learning, offer multiple benefits, such as data processing, enabling pharmacists to make quick data-backed decisions and improve customer services. Furthermore, with IoT, drug inventory management will be faster and more accurate; through device-to-device communication. To accelerate performance advancement, pharmacists must be skilled at using emerging technologies of all kinds.
Strategic Operations for Market Expansion by Vendors
The European e-pharmacy market is witnessing massive development with several business strategies implementation. Several strategic partnerships, collaborations, and mergers & acquisitions have been registered in the Europe e-pharmacy market in recent years. Some leading industry players are considering strategic and opportunistic acquisitions of other companies, businesses, or assets. In 2023, the leading industry player SHOP APOTHEKE EUROPE and Galenica entered a strategic partnership and established MediService Ltd leading online pharmacy in Switzerland.
SEGMENTATION INSIGHTS
INSIGHTS BY MEDICINE TYPE
The Europe e-pharmacy market by medicine type is segmented into over-the-counter (OTC) and prescription. OTC medicine types, including health & wellness and nutrition, dietary supplements, personal care, and cosmetic care solutions, are commonly and majorly ordered by people. The OTC segment accounted for the largest segmental revenue share in 2022. In Europe, most countries experienced a high demand for OTC products. In 2018, Roblek et al. found that customer expresses three typical online behaviors of OTC drugs: searching for information about OTC medicines without any particular purpose, buying OTC medicines, and searching for products or information.
Segmentation by Medicine Type
- OTC
- Prescription
INSIGHTS BY PLATFORM
The mobile platform segment accounted for the largest revenue share in the Europe e-pharmacy market in 2022. The increasing prevalence of chronic diseases drives awareness about medications and therapies in developed countries such as Germany, France, Switzerland, Italy, the UK, Spain, and others witnessed increasing use of mobile devices and associated applications to buy medicines online. Online pharmacies are witnessing the high growth and demand for medicines through smartphones and tablets.
Segmentation by Platform
- Mobile
- Desktop
INSIGHTS BY AGE GROUP
The below-50 age group segment dominated the Europe e-pharmacy market share in 2022. The below-50 age group highly uses internet services & smartphones and highly prefers buying medicine from online pharmacies. The penetration of e-commerce shopping preference accelerates the higher segmental growth.
Segmentation by Age Group
- Below 50
- Above 50
INSIGHTS BY PRODUCT
The Europe e-pharmacy market by product types includes medications, health & wellness and nutrition, personal care & essentials, and others. The medications segment accounted for the industry's highest revenue share of over 75% in 2022. Online pharmacies purchase mostly prescription drugs associated with viral infections such as cold and flu, cough, diabetes-associated drugs, cancer care drugs, etc. On another side, opioids, slimming tablets, and hypnotic and sedative agents are some of the prescription medicines highly sold in Europe.
Segmentation by Product
- Medications
- Health & Wellness and Nutrition
- Personal Care & Essentials
- Others
REGIONAL ANALYSIS
EU-4 & UK is a major region in the Europe e-pharmacy market with high development in the pharmaceutical industry, research and development, production, sale, marketing, and distribution. The huge patient population and higher patient health expenditures are accelerating the application rate of e-pharmacy websites and mobile applications. In 2022, EU-4 & UK region accounted for the highest share of over 59% in the Europe e-pharmacy market. In EU-4 & UK region, major countries such as Germany and the UK have made major progress in the e-pharmacy network. The presence of major and emerging e-pharmacies accelerates regional growth. On another side, the growing patient population and rising expenditure on health propelling regional growth. Furthermore, Italy and Spain have shown rapid growth in e-pharmacies.
Segmentation by Geography
- EU-4 & UK
- Germany
- UK
- France
- Italy
- Spain
- Central and Eastern Europe
- Poland
- Netherlands
- Russia
- Switzerland
- Czech Republic
- Nordic Countries
- Denmark
- Sweden
- Norway
- Finland
- Iceland
VENDOR LANDSCAPE
In the Europe e-pharmacy market, several local/traditional/offline and online pharmacies are present in the region, significantly driving the competitive rivalry. In addition, the access to e-commerce channels and their involvement in medication deliveries make the European e-pharmacy market highly competitive. The e-commerce channels allow European pharmacies to provide/offer a wider range of products than local pharmacies, not constrained by the amount of physical shelf storage space.
Key Company Profiles
- DocMorris AG (Zur Rose Group)
- Shop Apotheke
Other Prominent Vendors
- AMX Holdings
- Apteka.ru
- Apotea
- Apoteket
- AZETA
- BestPharmacy
- Chemist4U
- Chemist Direct
- Cocooncenter
- DeOnlineDrogist
- ePharmacy (EAPTEKA)
- Euro-Pharmas
- Express Pharmacy
- EVERER GmbH
- Farmacia Internacional
- Helsinki University Pharmacy [Yliopiston Apteekki] (YA)
- Index Medical
- INHOUSE PHARMACY
- Juvalis
- Lekarna WPK
- Lloyds Pharmacy
- Lekarnar
- Lyf og heilsa hf.
- Lyfjaver
- MedExpress Enterprises
- MonCoinSante
- Mistletoe Pharmacy
- myCARE
- MediService AG
- Mediservice Ltd
- MEDS
- Newpharma
- Oxford Online Pharmacy
- Prvalekarna
- Parafarmacia-online
- Pharmacy2U
- Pharmacy Direct GB
- Pharm24
- PROTEK Group
- SBER EAPTEKA
- Simple Online Pharmacy
- The independent pharmacy
- The French pharmacy
- UK Meds Direct
- WebMed Pharmacy
- Pharmacy4u
- Vamida
KEY QUESTIONS ANSWERED:
- 1. How big is the Europe e-pharmacy market?
- 2. What is the growth rate of the Europe e-pharmacy market?
- 3. What are the growing trends in the Europe e-pharmacy market?
- 4. Which region holds the most significant Europe e-pharmacy market share?
- 5. Who are the key players in the Europe e-pharmacy market?
TABLE OF CONTENTS
1 RESEARCH METHODOLOGY
2 RESEARCH OBJECTIVES
3 RESEARCH PROCESS
4 SCOPE & COVERAGE
- 4.1 MARKET DEFINITION
- 4.1.1 INCLUSIONS
- 4.1.2 EXCLUSIONS
- 4.1.3 MARKET ESTIMATION CAVEATS
- 4.2 BASE YEAR
- 4.3 SCOPE OF THE STUDY
- 4.3.1 MARKET SEGMENTATION BY MEDICINE TYPE
- 4.3.2 MARKET SEGMENTATION BY PLATFORM
- 4.3.3 MARKET SEGMENTATION BY PRODUCT TYPE
- 4.3.4 MARKET SEGMENTATION BY AGE GROUP
5 REPORT ASSUMPTIONS & CAVEATS
- 5.1 KEY CAVEATS
- 5.2 CURRENCY CONVERSION
- 5.3 MARKET DERIVATION
6 PREMIUM INSIGHTS
- 6.1 OVERVIEW
7 MARKET AT A GLANCE
8 INTRODUCTION
- 8.1 OVERVIEW
- 8.1.1 EUROPE E-PHARMACY MARKET OUTLOOK
- 8.1.2 GLOBAL E-PHARMACY MARKET OUTLOOK
9 MARKET OPPORTUNITIES & TRENDS
- 9.1 INCREASED E-HEALTH & E-PRESCRIPTION SERVICES
- 9.2 INTEGRATION OF ARTIFICIAL INTELLIGENCE & INTERNET OF THINGS
- 9.3 STRATEGIC ACQUISITIONS FOR MARKET EXPANSION
- 9.4 INTEGRATION OF E-PHARMACIES WITH DELIVERY MANAGEMENT SOLUTIONS
10 MARKET GROWTH ENABLERS
- 10.1 INTERNET PENETRATION AMONG PATIENT POPULATION
- 10.2 INCREASED HOME HEALTHCARE DELIVERIES
- 10.3 INCREASED HEALTH AWARENESS & SELF-MEDICATION
- 10.4 INCREASED PATIENT POPULATION
11 MARKET RESTRAINTS
- 11.1 STRINGENT REGULATORY NORMS
- 11.2 DATA BREACH & PRIVACY ISSUES
- 11.3 COMPETITION FROM TRADITIONAL PHARMACIES
12 MARKET LANDSCAPE
- 12.1 MARKET OVERVIEW
- 12.1.1 MARKET BY MEDICINE TYPE
- 12.1.2 MARKET BY PLATFORM
- 12.1.3 MARKET BY AGE GROUP
- 12.1.4 MARKET BY PRODUCT TYPE
- 12.1.5 MARKET BY REGION
- 12.2 MARKET SIZE & FORECAST
- 12.3 FIVE FORCES ANALYSIS
- 12.3.1 THREAT OF NEW ENTRANTS
- 12.3.2 BARGAINING POWER OF SUPPLIERS
- 12.3.3 BARGAINING POWER OF BUYERS
- 12.3.4 THREAT OF SUBSTITUTES
- 12.3.5 COMPETITIVE RIVALRY
13 MEDICINE TYPE
- 13.1 MARKET SNAPSHOT & GROWTH ENGINE
- 13.2 MARKET OVERVIEW
- 13.3 OTC
- 13.3.1 MARKET OVERVIEW
- 13.3.2 MARKET SIZE & FORECAST
- 13.3.3 MARKET BY GEOGRAPHY
- 13.4 RX
- 13.4.1 MARKET OVERVIEW
- 13.4.2 MARKET SIZE & FORECAST
- 13.4.3 MARKET BY GEOGRAPHY
14 PLATFORM
- 14.1 MARKET SNAPSHOT & GROWTH ENGINE
- 14.2 MARKET OVERVIEW
- 14.3 MOBILE
- 14.3.1 MARKET OVERVIEW
- 14.3.2 MARKET SIZE & FORECAST
- 14.3.3 MARKET BY GEOGRAPHY
- 14.4 DESKTOP
- 14.4.1 MARKET OVERVIEW
- 14.4.2 MARKET SIZE & FORECAST
- 14.4.3 MARKET BY GEOGRAPHY
15 AGE GROUP
- 15.1 MARKET SNAPSHOT & GROWTH ENGINE
- 15.2 MARKET OVERVIEW
- 15.3 BELOW 50
- 15.3.1 MARKET OVERVIEW
- 15.3.2 MARKET SIZE & FORECAST
- 15.3.3 MARKET BY GEOGRAPHY
- 15.4 ABOVE 50
- 15.4.1 MARKET OVERVIEW
- 15.4.2 MARKET SIZE & FORECAST
- 15.4.3 MARKET BY GEOGRAPHY
16 PRODUCT TYPE
- 16.1 MARKET SNAPSHOT & GROWTH ENGINE
- 16.2 MARKET OVERVIEW
- 16.3 MEDICATION
- 16.3.1 MARKET OVERVIEW
- 16.3.2 MARKET SIZE & FORECAST
- 16.3.3 MARKET BY GEOGRAPHY
- 16.4 HEALTH, WELLNESS & NUTRITION
- 16.4.1 MARKET OVERVIEW
- 16.4.2 MARKET SIZE & FORECAST
- 16.4.3 MARKET BY GEOGRAPHY
- 16.5 PERSONAL CARE & ESSENTIALS
- 16.5.1 MARKET OVERVIEW
- 16.5.2 MARKET SIZE & FORECAST
- 16.5.3 MARKET BY GEOGRAPHY
- 16.6 OTHERS
- 16.6.1 MARKET OVERVIEW
- 16.6.2 MARKET SIZE & FORECAST
- 16.6.3 MARKET BY GEOGRAPHY
17 REGION
- 17.1 MARKET SNAPSHOT & GROWTH ENGINE
- 17.2 REGIONAL OVERVIEW
18 EU-4 & UK
- 18.1 MARKET OVERVIEW
- 18.2 MARKET SIZE & FORECAST
- 18.3 MEDICINE TYPE
- 18.3.1 MARKET SIZE & FORECAST
- 18.4 PLATFORM
- 18.4.1 MARKET SIZE & FORECAST
- 18.5 AGE GROUP
- 18.5.1 MARKET SIZE & FORECAST
- 18.6 PRODUCT TYPE
- 18.6.1 MARKET SIZE & FORECAST
- 18.7 KEY COUNTRIES
- 18.7.1 GERMANY: MARKET SIZE & FORECAST
- 18.7.2 UK: MARKET SIZE & FORECAST
- 18.7.3 FRANCE: MARKET SIZE & FORECAST
- 18.7.4 ITALY: MARKET SIZE & FORECAST
- 18.7.5 SPAIN: MARKET SIZE & FORECAST
19 CENTRAL & EASTERN EUROPE
- 19.1 MARKET OVERVIEW
- 19.2 MARKET SIZE & FORECAST
- 19.3 MEDICINE TYPE
- 19.3.1 MARKET SIZE & FORECAST
- 19.4 PLATFORM
- 19.4.1 MARKET SIZE & FORECAST
- 19.5 AGE GROUP
- 19.5.1 MARKET SIZE & FORECAST
- 19.6 PRODUCT TYPE
- 19.6.1 MARKET SIZE & FORECAST
- 19.7 KEY COUNTRIES
- 19.7.1 POLAND: MARKET SIZE & FORECAST
- 19.7.2 NETHERLANDS: MARKET SIZE & FORECAST
- 19.7.3 RUSSIA: MARKET SIZE & FORECAST
- 19.7.4 SWITZERLAND: MARKET SIZE & FORECAST
- 19.7.5 CZECH REPUBLIC: MARKET SIZE & FORECAST
20 NORDIC COUNTRIES
- 20.1 MARKET OVERVIEW
- 20.2 MARKET SIZE & FORECAST
- 20.3 MEDICINE TYPE
- 20.3.1 MARKET SIZE & FORECAST
- 20.4 PLATFORM
- 20.4.1 MARKET SIZE & FORECAST
- 20.5 AGE GROUP
- 20.5.1 MARKET SIZE & FORECAST
- 20.6 PRODUCT TYPE
- 20.6.1 MARKET SIZE & FORECAST
- 20.7 KEY COUNTRIES
- 20.7.1 DENMARK: MARKET SIZE & FORECAST
- 20.7.2 SWEDEN: MARKET SIZE & FORECAST
- 20.7.3 NORWAY: MARKET SIZE & FORECAST
- 20.7.4 FINLAND: MARKET SIZE & FORECAST
- 20.7.5 ICELAND: MARKET SIZE & FORECAST
21 COMPETITIVE LANDSCAPE
- 21.1 COMPETITION OVERVIEW
- 21.2 MARKET SHARE ANALYSIS
22 KEY COMPANY PROFILES
- 22.1 DOCMORRIS AG (ZUR ROSE GROUP)
- 22.1.1 BUSINESS OVERVIEW
- 22.1.2 KEY STRATEGIES
- 22.1.3 KEY STRENGTHS
- 22.1.4 KEY OPPORTUNITIES
- 22.2 SHOP APOTHEKE
- 22.2.1 BUSINESS OVERVIEW
- 22.2.2 KEY STRATEGIES
- 22.2.3 KEY STRENGTHS
- 22.2.4 KEY OPPORTUNITIES
23 OTHER PROMINENT VENDORS
- 23.1 AMX HOLDINGS
- 23.1.1 BUSINESS OVERVIEW
- 23.1.2 KEY STRATEGIES
- 23.1.3 KEY STRENGTHS
- 23.2 APTEKA.RU
- 23.2.1 BUSINESS OVERVIEW
- 23.2.2 KEY STRATEGIES
- 23.2.3 KEY STRENGTHS
- 23.3 APOTEA
- 23.3.1 BUSINESS OVERVIEW
- 23.3.2 KEY STRATEGIES
- 23.3.3 KEY STRENGTHS
- 23.4 APOTEKET
- 23.4.1 BUSINESS OVERVIEW
- 23.4.2 KEY STRATEGIES
- 23.4.3 KEY STRENGTHS
- 23.5 AZETA
- 23.5.1 BUSINESS OVERVIEW
- 23.5.2 KEY STRATEGIES
- 23.5.3 KEY STRENGTHS
- 23.6 BESTPHARMACY
- 23.6.1 BUSINESS OVERVIEW
- 23.6.2 KEY STRATEGIES
- 23.6.3 KEY STRENGTHS
- 23.7 CHEMIST4U
- 23.7.1 BUSINESS OVERVIEW
- 23.7.2 KEY STRATEGIES
- 23.7.3 KEY STRENGTHS
- 23.8 CHEMIST DIRECT
- 23.8.1 BUSINESS OVERVIEW
- 23.8.2 KEY STRATEGIES
- 23.8.3 KEY STRENGTHS
- 23.9 COCOONCENTER
- 23.9.1 BUSINESS OVERVIEW
- 23.9.2 KEY STRATEGIES
- 23.9.3 KEY STRENGTHS
- 23.10 DEONLINEDROGIST
- 23.10.1 BUSINESS OVERVIEW
- 23.10.2 KEY STRATEGIES
- 23.10.3 KEY STRENGTHS
- 23.11 EPHARMACY (EAPTEKA)
- 23.11.1 BUSINESS OVERVIEW
- 23.11.2 KEY STRATEGIES
- 23.11.3 KEY STRENGTHS
- 23.12 EURO-PHARAMAS
- 23.12.1 BUSINESS OVERVIEW
- 23.12.2 KEY STRATEGIES
- 23.12.3 KEY STRENGTHS
- 23.13 EXPRESS PHARMACY
- 23.13.1 BUSINESS OVERVIEW
- 23.13.2 KEY STRATEGIES
- 23.13.3 KEY STRENGTHS
- 23.14 EVERER GMBH
- 23.14.1 BUSINESS OVERVIEW
- 23.14.2 KEY STRATEGIES
- 23.14.3 KEY STRENGTHS
- 23.15 FRAMACIA INTERNACIONAL
- 23.15.1 BUSINESS OVERVIEW
- 23.15.2 KEY STRATEGIES
- 23.15.3 KEY STRENGTHS
- 23.16 HELSINKI UNIVERSITY PHARMACY [YLIOPISTAN APTEEKKI] (YA)
- 23.16.1 BUSINESS OVERVIEW
- 23.16.2 KEY STRATEGIES
- 23.16.3 KEY STRENGTHS
- 23.17 INDEX MEDICAL
- 23.17.1 BUSINESS OVERVIEW
- 23.17.2 KEY STRATEGIES
- 23.17.3 KEY STRENGTHS
- 23.18 INHOUSE PHARMACY
- 23.18.1 BUSINESS OVERVIEW
- 23.18.2 KEY STRATEGIES
- 23.18.3 KEY STRENGTHS
- 23.19 JUVALIS
- 23.19.1 BUSINESS OVERVIEW
- 23.19.2 KEY STRATEGIES
- 23.19.3 KEY STRENGTHS
- 23.20 LEKARNA WPK
- 23.20.1 BUSINESS OVERVIEW
- 23.20.2 KEY STRATEGIES
- 23.20.3 KEY STRENGTHS
- 23.21 LLOYDS PHARMACY
- 23.21.1 BUSINESS OVERVIEW
- 23.21.2 KEY STRATEGIES
- 23.21.3 KEY STRENGTHS
- 23.22 LEKARNAR
- 23.22.1 BUSINESS OVERVIEW
- 23.22.2 KEY STRATEGIES
- 23.22.3 KEY STRENGTHS
- 23.23 LYF OG HEILSA
- 23.23.1 BUSINESS OVERVIEW
- 23.23.2 KEY STRATEGIES
- 23.23.3 KEY STRENGTHS
- 23.24 LYFJAVER
- 23.24.1 BUSINESS OVERVIEW
- 23.24.2 KEY STRATEGIES
- 23.24.3 KEY STRENGTHS
- 23.25 MEDEXPRESS ENTERPRISES
- 23.25.1 BUSINESS OVERVIEW
- 23.25.2 KEY STRATEGIES
- 23.25.3 KEY STRENGTHS
- 23.26 MONCOINSANTE
- 23.26.1 BUSINESS OVERVIEW
- 23.26.2 KEY STRATEGIES
- 23.26.3 KEY STRENGTHS
- 23.27 MISTLETOE PHARMACY
- 23.27.1 BUSINESS OVERVIEW
- 23.27.2 KEY STRATEGIES
- 23.27.3 KEY STRENGTHS
- 23.28 MYCARE
- 23.28.1 BUSINESS OVERVIEW
- 23.28.2 KEY STRATEGIES
- 23.28.3 KEY STRENGTHS
- 23.29 MEDISERVICE AG
- 23.29.1 BUSINESS OVERVIEW
- 23.29.2 KEY STRATEGIES
- 23.29.3 KEY STRENGTHS
- 23.30 MEDSERVICE LTD
- 23.30.1 BUSINESS OVERVIEW
- 23.30.2 KEY STRATEGIES
- 23.30.3 KEY STRENGTHS
- 23.31 MEDS
- 23.31.1 BUSINESS OVERVIEW
- 23.31.2 KEY STRATEGIES
- 23.31.3 KEY STRENGTHS
- 23.32 NEWPHARMA
- 23.32.1 BUSINESS OVERVIEW
- 23.32.2 KEY STRATEGIES
- 23.32.3 KEY STRENGTHS
- 23.33 OXFORD ONLINE PHARMACY
- 23.33.1 BUSINESS OVERVIEW
- 23.33.2 KEY STRATEGIES
- 23.33.3 KEY STRENGTHS
- 23.34 PRVALEKARNA
- 23.34.1 BUSINESS OVERVIEW
- 23.34.2 KEY STRATEGIES
- 23.34.3 KEY STRENGTHS
- 23.35 PARAFARMACIA-ONLINE
- 23.35.1 BUSINESS OVERVIEW
- 23.35.2 KEY STRATEGIES
- 23.35.3 KEY STRENGTHS
- 23.36 PHARMACY2U
- 23.36.1 BUSINESS OVERVIEW
- 23.36.2 KEY STRATEGIES
- 23.36.3 KEY STRENGTHS
- 23.37 PHARMACY DIRECT GB
- 23.37.1 BUSINESS OVERVIEW
- 23.37.2 KEY STRATEGIES
- 23.37.3 KEY STRENGTHS
- 23.38 PHARMA24
- 23.38.1 BUSINESS OVERVIEW
- 23.38.2 KEY STRATEGIES
- 23.38.3 KEY STRENGTHS
- 23.39 PROTEK GROUP
- 23.39.1 BUSINESS OVERVIEW
- 23.39.2 KEY STRATEGIES
- 23.39.3 KEY STRENGTHS
- 23.40 SBER EAPTEKA
- 23.40.1 BUSINESS OVERVIEW
- 23.40.2 KEY STRATEGIES
- 23.40.3 KEY STRENGTHS
- 23.41 SIMPLE ONLINE PHARMACY
- 23.41.1 BUSINESS OVERVIEW
- 23.41.2 KEY STRATEGIES
- 23.41.3 KEY STRENGTHS
- 23.42 THE INDEPENDENT PHARMACY
- 23.42.1 BUSINESS OVERVIEW
- 23.42.2 KEY STRATEGIES
- 23.42.3 KEY STRENGTHS
- 23.43 THE FRENCH PHARMACY
- 23.43.1 BUSINESS OVERVIEW
- 23.43.2 KEY STRATEGIES
- 23.43.3 KEY STRENGTHS
- 23.44 UK MEDS DIRECT
- 23.44.1 BUSINESS OVERVIEW
- 23.44.2 KEY STRATEGIES
- 23.44.3 KEY STRENGTHS
- 23.45 WEBMED PHARMACY
- 23.45.1 BUSINESS OVERVIEW
- 23.45.2 KEY STRATEGIES
- 23.45.3 KEY STRENGTHS
- 23.46 PHARMACY4U
- 23.46.1 BUSINESS OVERVIEW
- 23.46.2 KEY STRATEGIES
- 23.46.3 KEY STRENGTHS
- 23.47 VAMIDA
- 23.47.1 BUSINESS OVERVIEW
- 23.47.2 KEY STRATEGIES
- 23.47.3 KEY STRENGTHS
24 REPORT SUMMARY
- 24.1 KEY TAKEAWAYS
- 24.2 STRATEGIC RECOMMENDATIONS
25 QUANTITATIVE SUMMARY
- 25.1 MARKET BY REGION
- 25.2 MARKET BY MEDICINE TYPE
- 25.3 MARKET BY PLATFORM
- 25.4 MARKET BY AGE GROUP
- 25.5 MARKET BY PRODUCT TYPE
- 25.6 EU-4 & UK: MARKET SEGMENTATION
- 25.6.1 EU-4 & UK E-PHARMACY MARKET BY MEDICINE TYPE
- 25.6.2 EU-4 & UK E-PHARMACY MARKET BY PLATFORM
- 25.6.3 EU-4 & UK E-PHARMACY MARKET BY AGE GROUP
- 25.6.4 EU-4 & UK E-PHARMACY MARKET BY PRODUCT TYPE
- 25.7 CENTRAL & EASTERN EUROPE: MARKET SEGMENTATION
- 25.7.1 CENTRAL & EASTERN EUROPE E-PHARMACY MARKET BY MEDICINE TYPE
- 25.7.2 CENTRAL & EASTERN EUROPE E-PHARMACY MARKET BY PLATFORM
- 25.7.3 CENTRAL & EASTERN EUROPE E-PHARMACY MARKET BY AGE GROUP
- 25.7.4 CENTRAL & EASTERN EUROPE E-PHARMACY MARKET BY PRODUCT TYPE
- 25.8 NORDIC COUNTRIES: MARKET SEGMENTATION
- 25.8.1 NORDIC COUNTRIES E-PHARMACY MARKET BY MEDICINE TYPE
- 25.8.2 NORDIC COUNTRIES E-PHARMACY MARKET BY PLATFORM
- 25.8.3 NORDIC COUNTRIES E-PHARMACY MARKET BY AGE GROUP
- 25.8.4 NORDIC COUNTRIES E-PHARMACY MARKET BY PRODUCT TYPE
26 APPENDIX
- 26.1 ABBREVIATIONS
